Statins in stroke: Prevention, protection and recovery

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

Stroke is the third most common cause of death and the leading cause of neurological disability in the USA. While some risk factors for stroke, such as hypertension and cigarette smoking, are well defined, the role of cholesterol in stroke pathogenesis is debated. However, numerous studies in the past decade have shown that medications that reduce cholesterol via 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition (statins) reduce the incidence of ischemic stroke in patients who are known to have, or be at high risk of, coronary artery disease. In addition, statins may have benefits in neuroprotection and recovery after stroke. The mechanisms by which statins protect against, and improve outcome after, stroke probably extend beyond lipid lowering.

Original languageEnglish (US)
Pages (from-to)195-202
Number of pages8
JournalExpert Review of Neurotherapeutics
Volume6
Issue number2
DOIs
StatePublished - Feb 1 2006

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Stroke
Cholesterol
Coronary Artery Disease
Cause of Death
Oxidoreductases
Smoking
Hypertension
Lipids
Incidence

Keywords

  • Acute stroke
  • Cholesterol
  • Nitric oxide
  • Prevention
  • Statins

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Statins in stroke : Prevention, protection and recovery. / Switzer, Jeffrey A; Hess, David C.

In: Expert Review of Neurotherapeutics, Vol. 6, No. 2, 01.02.2006, p. 195-202.

Research output: Contribution to journalReview article

@article{be2b77f7cd434138b3b8725cb13d72bc,
title = "Statins in stroke: Prevention, protection and recovery",
abstract = "Stroke is the third most common cause of death and the leading cause of neurological disability in the USA. While some risk factors for stroke, such as hypertension and cigarette smoking, are well defined, the role of cholesterol in stroke pathogenesis is debated. However, numerous studies in the past decade have shown that medications that reduce cholesterol via 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition (statins) reduce the incidence of ischemic stroke in patients who are known to have, or be at high risk of, coronary artery disease. In addition, statins may have benefits in neuroprotection and recovery after stroke. The mechanisms by which statins protect against, and improve outcome after, stroke probably extend beyond lipid lowering.",
keywords = "Acute stroke, Cholesterol, Nitric oxide, Prevention, Statins",
author = "Switzer, {Jeffrey A} and Hess, {David C}",
year = "2006",
month = "2",
day = "1",
doi = "10.1586/14737175.6.2.195",
language = "English (US)",
volume = "6",
pages = "195--202",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Statins in stroke

T2 - Prevention, protection and recovery

AU - Switzer, Jeffrey A

AU - Hess, David C

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Stroke is the third most common cause of death and the leading cause of neurological disability in the USA. While some risk factors for stroke, such as hypertension and cigarette smoking, are well defined, the role of cholesterol in stroke pathogenesis is debated. However, numerous studies in the past decade have shown that medications that reduce cholesterol via 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition (statins) reduce the incidence of ischemic stroke in patients who are known to have, or be at high risk of, coronary artery disease. In addition, statins may have benefits in neuroprotection and recovery after stroke. The mechanisms by which statins protect against, and improve outcome after, stroke probably extend beyond lipid lowering.

AB - Stroke is the third most common cause of death and the leading cause of neurological disability in the USA. While some risk factors for stroke, such as hypertension and cigarette smoking, are well defined, the role of cholesterol in stroke pathogenesis is debated. However, numerous studies in the past decade have shown that medications that reduce cholesterol via 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition (statins) reduce the incidence of ischemic stroke in patients who are known to have, or be at high risk of, coronary artery disease. In addition, statins may have benefits in neuroprotection and recovery after stroke. The mechanisms by which statins protect against, and improve outcome after, stroke probably extend beyond lipid lowering.

KW - Acute stroke

KW - Cholesterol

KW - Nitric oxide

KW - Prevention

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=33645851972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645851972&partnerID=8YFLogxK

U2 - 10.1586/14737175.6.2.195

DO - 10.1586/14737175.6.2.195

M3 - Review article

C2 - 16466299

AN - SCOPUS:33645851972

VL - 6

SP - 195

EP - 202

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 2

ER -